Related Experiment Video
Updated: Apr 5, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease
Magdalena Jankowska1, Michał Chmielewski2, Monika Lichodziejewska-Niemierko2
1Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, ul. Dębinki 7, 81-211, Gdańsk, Poland. maja@gumed.edu.pl.
Insights
Peritoneal dialysis (PD) is a viable option for Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients. While ADPKD patients had a higher risk of hernias and leaks, dialysis adequacy and survival rates were similar to non-ADPKD patients.
Area of Science:
- Nephrology
- Renal Replacement Therapy
Background:
- Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disorder.
- Peritoneal dialysis (PD) is often avoided in ADPKD due to perceived risks.
- Limited comparative data exists for PD in ADPKD patients.
Purpose of the Study:
- To compare dialysis adequacy and outcomes in ADPKD patients undergoing PD versus non-ADPKD patients.
- To evaluate the safety and efficacy of PD as a treatment for end-stage renal disease in ADPKD.
Main Methods:
- Retrospective analysis of a national PD registry.
- Inclusion of 106 ADPKD and 1606 non-ADPKD incident PD patients.
- Comparison of dialysis adequacy, complication rates, and survival between groups.
Main Results:
- No significant difference in dialysis adequacy between ADPKD and non-ADPKD groups.
- Similar patient and technique survival rates after a median follow-up of 32 months.
- ADPKD patients exhibited a twofold higher risk of abdominal hernias and fluid leaks, without necessitating permanent hemodialysis transfer.
Conclusions:
- Peritoneal dialysis demonstrates comparable efficacy and survival to non-ADPKD patients.
- Despite increased risk of specific complications, PD is a feasible treatment for ADPKD patients with end-stage renal failure.
Purpose:
When choosing a dialysis option for ADPKD patients, peritoneal dialysis (PD) is often discouraged, due to its potential drawbacks: risk of abdominal hernias and dialysis fluid leaks, risk of peritonitis and insufficient dialysis adequacy. The present study was designed to compare the outcomes and dialysis efficacy in ADPKD patients treated with PD, in comparison with non-ADPKD subjects.
Methods:
This study was a retrospective analysis of the data from the national PD registry in which 106 ADPKD and 1606 non-ADPKD incident PD patients were evaluated. Data on dialysis adequacy, risk of dialysis-associated complications, as well as patient and technique survival were compared between the groups.
Results:
The ADPKD patients did not differ from the non-ADPKD controls in terms of dialysis adequacy. After a median observation time of 32 months, there were no differences in patient or technique survival. The risk of abdominal hernias and dialysis fluid leaks was twice as high in ADPKD subjects, compared to the non-ADPKD group. However, these complications did not result in a need for a permanent transfer to hemodialysis.
Conclusions:
Dialysis adequacy, and patient and technique survival are similar in the ADPKD and non-ADPKD patients treated with PD. PD seems a feasible treatment option for end-stage renal failure in the course of ADPKD.
More Related Videos
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Chronic Kidney Disease I: Introduction

